# Prostate Cancer Screening With Abbreviated MRI Protocol

> **NCT05603351** · NA · UNKNOWN · sponsor: **Masaryk Memorial Cancer Institute** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** magnetic resonance
- **DIAGNOSTIC_TEST:** serum PSA examination
- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT05603351
- **Lead sponsor:** Masaryk Memorial Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05603351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05603351, "Prostate Cancer Screening With Abbreviated MRI Protocol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05603351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*